SI
KANG

Sensato Investors’s iKang Healthcare Group, Inc. KANG Stock Holding History

Sensato Investors’s Portfolio KANG Stock Details KANG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,400
Closed -$206K – 115
2018
Q3 		$206K Buy
+11,400
New +$220K 0.04% 89

Other funds holding KANG

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CFIC
City Financial Investment Company London, United Kingdom $562M AUM 5.93% 1-Year Est. Return
CI
Conning Inc Hartford, Connecticut $3.34B AUM 25.19% 1-Year Est. Return

Sensato Investors's KANG Position: Q4 2018 in Review

Sensato Investors sold out of iKang Healthcare Group, Inc. (KANG) in Q4 2018, closing a stake of 11,400 shares — an estimated $206K sold.

Sensato Investors first reported a position in KANG in Q3 2018 and held it in 1 quarter. The position peaked at $206K in Q3 2018. 54 funds tracked by Wall St. Rank hold KANG as of Q4 2018.

  • Sensato Investors reported no remaining iKang Healthcare Group, Inc. position as of Q4 2018 after selling out during the quarter.
  • Sensato Investors sold 11,400 iKang Healthcare Group, Inc. shares in Q4 2018, an estimated $206K.
  • Sensato Investors first reported a position in iKang Healthcare Group, Inc. in Q3 2018 and held it in 1 quarter.
  • Sensato Investors's iKang Healthcare Group, Inc. position peaked at $206K in Q3 2018.
  • 54 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q4 2018.

Based on Sensato Investors's 13F filing for Q4 2018, filed 14 Feb 2019.